The Times 20 August 2014
On the twelfth floor of Guy’s Hospital, next to the Shard, is a gleaming laboratory with panoramic views of London. To the untrained eye, it looks rather like a room full of photocopiers, microwaves and washing machines — but the equipment in here sets pulses racing for the scientists who come to stir, spin, modify, test and manufacture cells within its spotless glass walls.
This is the heart of the cell therapy string of the government’s Catapult programme, which invests in areas of leading academic research, in this case designed to drive the growth of a revolutionary form of treatment that proponents say will cure cancer and make the blind see.
Chris Denning, professor of stem cell biology at the University of Nottingham, says: “If we can achieve even a fraction